Paul Hastings Advised SD Biosensor and SJL Partners in Acquisition of Meridian Bioscience

February 06, 2023

Paul Hastings LLP advised SD Biosensor and SJL Partners in their acquisition of Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading global provider of diagnostic testing solutions and life science raw materials. Meridian stock will no longer be traded on the NASDAQ Global Select Market and its shareholders will have the right to receive $34 per share. The company will continue to operate as an independent entity. The transaction closed on January 31, 2023.

The deal has been shortlisted for Cross-Border M&A Deal of the Year at Law.com International’s Asia Legal Awards 2023.

Corporate partners Robert Leung and Iksoo Kim led the Paul Hastings team, which also included associates Vinnie Buehler, Celina Hong, and Anna Hardcastle.

The team was supported by Regulatory and Enforcement partner Peter Lindsay; Regulatory and Enforcement associates Jesselyn Pe and Hanna Ali; Antitrust partners Michael Wise and Camille Paulhac; Antitrust associates Juliette Hua and Mary Walser; Tax partner Michael Haun; Employee Benefits partner Eric Keller; Employee Benefits associate Bill McCue; IP partner Todd Schneider; IP associates Laura Yip and April White; Finance partner Holly Snow; Finance associates Gabriella Pan, Anthony Gunnell and Kassia Lewis-Deboos; Litigation partner Kevin Broughel; Capital Markets of counsel Alex Herman; Capital Markets associate Max Roberts; Real Estate partners Bradley Ritter and Thomas Mounteer; Real Estate associate Matt Seely; Privacy and Data Security associate David Coogan; Global Trade Controls partner Scott Flicker; Global Trade Controls of counsel Randall Johnston; Global Trade Controls associates Talya Hutchison and Ryan Poitras; Anti-Corruption of counsel Jennifer Riddle; Anti-Corruption associate Damini Kunwar; and Private Equity partners Max Rosenberg and Ted Craig.

More details on the transaction can be found here.

 About Paul Hastings

With widely recognized elite teams in finance, mergers & acquisitions, private equity, restructuring and special situations, litigation, employment and real estate, Paul Hastings is a premier law firm providing superior intellectual capital and execution globally to the world’s leading investment banks, asset managers and corporations.

Practice Areas



Mergers and Acquisitions

Life Sciences and Healthcare

FDA Regulatory and Enforcement



Corporate, Litigation, Real Estate, Intellectual Property, Life Sciences, and Employment

Becca Hatton


Katy Foster


Miranda Ward

Submission Requests

Firmwide Inquiries

Elliott Frieder

Get In Touch With Us

Contact Us